An Evaluation of Patient Reported Outcomes and Clinical Outcomes

Purpose

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery: - Patient reported outcomes (PRO), using the EQ-5D questionnaire - Clinical outcomes

Condition

  • Post-Operative Complications in Cardiac Surgery

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects must have completed the REN-007 study to be eligible to participate in the Extension Study.

Exclusion Criteria

  • Subjects who did not complete the REN-007 study are not eligible to participate in the Extension Study. - Female subjects who become pregnant during the REN-007 study are not eligible to participate in the Extension Study.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
RBT-1 Patients undergoing CABG, valve, or combined CABG/valve surgery
  • Drug: RBT-1
    Intravenous administration
Placebo Patients undergoing CABG, valve, or combined CABG/valve surgery
  • Drug: Placebo
    Intravenous administration

Recruiting Locations

More Details

NCT ID
NCT06092970
Status
Active, not recruiting
Sponsor
Renibus Therapeutics, Inc.